TickerFacts.

Bioharvest Sciences Inc. (BHST): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$3.95M
Year ended 2025-12-31
2023-12-31: -$9.13M2024-12-31: -$5.74M2025-12-31: -$3.95M-$3.95M
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$3.95Mn/m2026-03-31, From 2025-01-01
2024-12-31-$5.74Mn/m2026-03-31, From 2024-01-01
2023-12-31-$9.13Mn/a2025-03-31, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31-$3.95Mn/m
Sunshine Biopharma Inc. (SBFM)2025-12-31-$5.89Mn/m
Lftd Partners Inc. (LIFD)2025-12-31$1.47Mn/m
BGM Group Ltd. (BGM)2025-09-30-$11.12Mn/m
Foghorn Therapeutics Inc. (FHTX)2025-12-31-$83.06Mn/m
Biofrontera Inc. (BFRI)2025-12-31-$11.21Mn/m
Cue Biopharma, Inc. (CUE)2025-12-31-$25.59Mn/m
Xilio Therapeutics, Inc. (XLO)2025-12-31-$40.44Mn/m
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$1.35Mn/m

Compare BHST, SBFM, LIFD, BGM side by side · Screen every company in Pharmaceutical Preparations ↗